MicroRNAs: Novel Regulators Involved in the Pathogenesis of Psoriasis?
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
MicroRNAs are a recently discovered class of posttranscriptional regulators of gene expression with critical functions in health and disease. Psoriasis is the most prevalent chronic inflammatory skin disease in adults, with a substantial negative impact on the patients' quality of life. Here we show for the first time that psoriasis-affected skin has a specific microRNA expression profile when compared with healthy human skin or with another chronic inflammatory skin disease, atopic eczema. Among the psoriasis-specific microRNAs, we identified leukocyte-derived microRNAs and one keratinocyte-derived microRNA, miR-203. In a panel of 21 different human organs and tissues, miR-203 showed a highly skin-specific expression profile. Among the cellular constituents of the skin, it was exclusively expressed by keratinocytes. The up-regulation of miR-203 in psoriatic plaques was concurrent with the down-regulation of an evolutionary conserved target of miR-203, suppressor of cytokine signaling 3 (SOCS-3), which is involved in inflammatory responses and keratinocyte functions. Our results suggest that microRNA deregulation is involved in the pathogenesis of psoriasis and contributes to the dysfunction of the cross talk between resident and infiltrating cells. Taken together, a new layer of regulatory mechanisms is involved in the pathogenesis of chronic inflammatory skin diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Its overexpression in human psoriatic skin has been suggested to reflect insufficient compensation of overt skin inflammation.91”
From The Innate Immune System in Acute and Chronic Wounds (2016) · cites this paper as [91]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
In silico prediction of protein-protein interactions in human macrophages
Souiai, O., Guerfali, F., Ben Miled, S., Brun, C., & Benkahla, A. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-157 · Cited by 10,803
The functions of animal microRNAs
Ambros, V. (2004) · Nature · doi:10.1038/nature02871 · Cited by 10,728
Significance analysis of microarrays applied to the ionizing radiation response
Tusher, V. G., Tibshirani, R., & Chu, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091062498 · Cited by 10,568
Taganov, K. D., Boldin, M. P., Chang, K.-J., & Baltimore, D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605298103 · Cited by 4,317 · cited 1×
“. Interestingly, a recent study showed that miR-146a, one of the psoriasis-specific miRNAs, inhibits the expression of IRAK-1 and TRAF-6 proteins both of which are regulators of the TNF-α signaling pathway”
BackgroundNon-coding RNAs and cancer: microRNAs and beyond
Raia, R. M., & Calin, G. A. (2011) · Journal of Nucleic Acids Investigation · doi:10.4081/jnai.2011.e5 · Cited by 3,382
Pathogenesis and therapy of psoriasis
Lowes, M. A., Bowcock, A. M., & Krueger, J. G. (2007) · Nature · doi:10.1038/nature05663 · Cited by 1,778 · cited 8×
“SOCS-3 deficiency leads to sustained activation of STAT3 in response to IL-6 [18], a cytokine present in the psoriasis lesions [11].”
BackgroundInfluentialmiRNAs, Cancer, and Stem Cell Division
Croce, C. M., & Calin, G. A. (2005) · Cell · doi:10.1016/j.cell.2005.06.036 · Cited by 1,329 · cited 1×
“. Indeed, miRNAs have regulatory roles in development, differentiation, organogenesis, stem cell and germline proliferation, growth control and apoptosis. Moreover, deregulation of miRNA expression may contribute to human diseases; in particular, miRNAs are often aberrantly expressed or mutated in cancer”
BackgroundPlasmacytoid predendritic cells initiate psoriasis through interferon-α production
Nestle, F. O., Conrad, C., Tun-Kyi, A., Homey, B., Gombert, M., Boyman, O., Burg, G., Liu, Y.-J., & Gilliet, M. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050500 · Cited by 1,124
Self-citationSOCS3 negatively regulates IL-6 signaling in vivo
Croker, B. A., Krebs, D. L., Zhang, J.-G., Wormald, S., Willson, T. A., Stanley, E. G., Robb, L., Greenhalgh, C. J., Förster, I., Clausen, B. E., et al. (2003) · Nature Immunology · doi:10.1038/ni931 · Cited by 840 · cited 1×
“SOCS-3 deficiency leads to sustained activation of STAT3 in response to IL-6 [18], a cytokine present in the psoriasis lesions [11].”
BackgroundSano, S., Chan, K. S., Carbajal, S., Clifford, J., Peavey, M., Kiguchi, K., Itami, S., Nickoloff, B. J., & DiGiovanni, J. (2005) · Nature Medicine · doi:10.1038/nm1162 · Cited by 752 · cited 3×
“In psoriasis, there is evidence for the pathogenic relevance of several different cell types that normally occur in skin: keratinocytes [12], fibroblasts [13], monocyte-derived immunocytes [11,14], T cells [15], and mast cells [16].”
BackgroundMorphogenesis in skin is governed by discrete sets of differentially expressed microRNAs
Yi, R., O'Carroll, D., Pasolli, H. A., Zhang, Z., Dietrich, F. S., Tarakhovsky, A., & Fuchs, E. (2006) · Nature Genetics · doi:10.1038/ng1744 · Cited by 555 · cited 1×
“Interestingly, miRNAs have been recently implicated in the morphogenesis of murine skin [20].”
BackgroundLebwohl, M. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12954-6 · Cited by 548
Expression and function of Toll-like receptors 2 and 4 in human keratinocytes
Pivarcsi, A. (2003) · International Immunology · doi:10.1093/intimm/dxg068 · Cited by 352 · cited 1×
“Cells Primary human keratinocytes, dermal fibroblasts and melanocytes were isolated from healthy skin using standard protocols and cultured as described [21,22].”
MethodSelf-citationDistinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis
Nomura, I., Gao, B., Boguniewicz, M., Darst, M. A., Travers, J. B., & Leung, D. Y. M. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2003.08.049 · Cited by 332
Homey, B., Wang, W., Soto, H., Buchanan, M. E., Wiesenborn, A., Catron, D., Müller, A., McClanahan, T. K., Dieu-Nosjean, M.-C., Orozco, R., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.7.3465 · Cited by 332
Self-citationZhou, X., Krueger, J. G., Kao, M.-C. J., Lee, E., Du, F., Menter, A., Wong, W. H., & Bowcock, A. M. (2003) · Physiological Genomics · doi:10.1152/physiolgenomics.00157.2002 · Cited by 295 · cited 1×
“Of note, these GO categories show significant overlap with the biological processes that are strongly perturbed in the psoriatic skin lesions [8].”
BackgroundInjection of Pre-Psoriatic Skin with CD4+ T Cells Induces Psoriasis
Nickoloff, B. J., & Wrone-Smith, T. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65109-7 · Cited by 260 · cited 1×
“In psoriasis, there is evidence for the pathogenic relevance of several different cell types that normally occur in skin: keratinocytes [12], fibroblasts [13], monocyte-derived immunocytes [11,14], T cells [15], and mast cells [16].”
BackgroundStratis, A. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27179 · Cited by 222 · cited 1×
“Therefore it is likely that this disease is the outcome of aberrantly activated mechanisms that do not necessarily depend on one single cell type but involve a variety of different cell populations [11,17].”
BackgroundFischer, M., Harvima, I. T., Carvalho, R. F. S., Möller, C., Naukkarinen, A., Enblad, G., & Nilsson, G. (2006) · Journal of Clinical Investigation · doi:10.1172/jci24274 · Cited by 141 · cited 1×
“In psoriasis, there is evidence for the pathogenic relevance of several different cell types that normally occur in skin: keratinocytes [12], fibroblasts [13], monocyte-derived immunocytes [11,14], T cells [15], and mast cells [16].”
BackgroundMicroRNAs as Therapeutic Targets
Czech, M. P. (2006) · New England Journal of Medicine · doi:10.1056/nejmcibr060065 · Cited by 129 · cited 1×
“Thus, miRNAs represent important targets for potential therapeutic and diagnostic agents [4].”
BackgroundIncreased Oxidative Damage to Fibroblasts in Skin With and Without Lesions in Psoriasis
Dimon-Gadal, S., Gerbaud, P., Guibourdenche, J., Evain‐Brion, D., Raynaud, F., Thérond, P., & Anderson, W. B. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00962.x · Cited by 71 · cited 1×
“In psoriasis, there is evidence for the pathogenic relevance of several different cell types that normally occur in skin: keratinocytes [12], fibroblasts [13], monocyte-derived immunocytes [11,14], T cells [15], and mast cells [16].”
BackgroundProteome Analysis of Skin Distinguishes Acute Guttate from Chronic Plaque Psoriasis
Carlén, L. M., Sánchez, F., Bergman, A., Becker, S., Hirschberg, D., Franzén, B., Coffey, J., Jörnvall, H., Auer, G., Alaiya, A. A., et al. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.23501.x · Cited by 56
Self-citationGoren, I., Linke, A., Müller, E., Pfeilschifter, J. M., & Frank, S. (2005) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700063 · Cited by 44 · cited 1×
“It has been shown that overexpression of SOCS-3 in keratinocytes leads to final differentiation and inhibits serum-stimulated proliferation [19].”
Background
Cited by
Nestle, F. O., Kaplan, D. H., & Barker, J. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804595 · Cited by 2,786
Transition from inflammation to proliferation: a critical step during wound healing
Landén, N. X., Li, D., & Ståhle, M. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2268-0 · Cited by 1,980
Self-citationmiRecords: an integrated resource for microRNA-target interactions
Xiao, F., Zuo, Z., Cai, G., Kang, S., Gao, X., & Li, T. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn851 · Cited by 1,438
“Indeed, it has become a common practice for experimental researchers to look at predictions made by several target prediction programs and focus on their intersections (30,31).”
BackgroundMicroRNAs in Development and Disease
Sayed, D., & Abdellatif, M. (2011) · Physiological Reviews · doi:10.1152/physrev.00006.2010 · Cited by 1,078
“Surely, only in psoriasis, miR-203 targets SOCS-3, which is a negative regulator in cytokine signaling pathways and keratinocyte proliferation (372) and is downregulated in the psoriatic lesions (571).”
BackgroundSheedy, F. J., Palsson-McDermott, E., Hennessy, E. J., Martin, C., O'Leary, J. J., Ruan, Q., Johnson, D. S., Chen, Y., & O'Neill, L. A. J. (2010) · Nature Immunology · doi:10.1038/ni.1828 · Cited by 1,005
Metadata
- Authors
- Sonkoly, E., Wei, T., Janson, P. C. J., Sääf, A., Lundeberg, L., Tengvall-Linder, M., Norstedt, G., Alenius, H., Homey, B., Scheynius, A., Ståhle, M., & Pivarcsi, A.
- Affiliations
- Karolinska Institutet (SE)
- Finnish Institute of Occupational Health (FI)
- Heinrich Heine University Düsseldorf (DE)
- Corresponding author
- Sonkoly, Enikö
- Pivarcsi, Andor
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2007-07-11
- Volume
- 2
- Issue
- 7
- Pages
- e610
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC1905940
- OpenAlex
- W1991320836
- Cited by
- 754
- References
- 24
- Citations by year
- 2026: 6 · 2025: 18 · 2024: 19 · 2023: 29 · 2022: 37 · 2021: 45 · 2020: 44 · 2019: 35 · 2018: 30 · 2017: 39 · 2016: 67 · 2015: 55 · 2014: 64 · 2013: 50 · 2012: 50
- FWCI
- 12.90
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Wenner-Gren Foundation
- Insamlingsstiftelsen Cancer- och Allergifonden
- Karolinska Institutet
- Stockholms Läns Landsting
- Szegedi Tudományegyetem
- Medical Research Council
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
- Keywords
- microRNA, psoriasis, miR-203, SOCS3, keratinocytes, miRNA expression profiling, atopic dermatitis, chronic inflammatory skin disease, post-transcriptional regulation, infiltrating immune cells
- MeSH terms
- Adult, Algorithms, Dermatitis, Atopic, Fibroblasts, Gene Expression Regulation, Humans, Mast Cells, Psoriasis, Quality of Life, Reference Values, Skin, Skin Physiological Phenomena, T-Lymphocytes, Blotting, Western, Keratinocytes, Gene Expression Profiling, MicroRNAs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.